cytovance.comBiologics contract development and manufacturing
Buyer list for Cytovance Biologics · Checked
12 biotech and pharma companies across 5 states that fit what Cytovance Biologics sells, each with the person who signs off.
We read cytovance.com to see what Cytovance Biologics sells, then checked each account below against it, one by one, and named the person who signs off at each. The first 5 are open below with work email and phone. The other 7 come with a short walkthrough call, and you keep the full list.
Tim Rath of Innovative Radiology on working with us
Checked
The opportunity for Cytovance Biologics
The accounts that fit what Cytovance Biologics sells, the market behind them, and who signs off.
12
accounts that fit Cytovance Biologics, each with the person who signs off
SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026
293
biological product makers in the US market
SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total
5
states on the list
SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026
01Buyer list for Cytovance Biologics
Each account checked one by one
First 5 of 12
7
more waiting
Each account fits what Cytovance Biologics sells, and each comes with the person who signs off. The first 5 carry a work email and a phone, checked on .
Company
Why it fits
Contact
Status
Compass Therapeutics Inc
Thomas Schuetz
Co-Founder, CEO, Vice Chairman of the Board
Boston, MA
Compass Therapeutics Inc is a clinical-stage oncology biopharmaceutical company developing antibody-based therapeutics.
Rezolute, Inc is a late-stage biotechnology company developing a monoclonal antibody for hyperinsulinism. Cytovance Biologics runs process development and cGMP manufacturing for antibodies, fusion proteins and enzymes.
nevan@rezolutebio.com+1 650 810 3021
Checked
Trellis Bioscience Inc
Stefan Ryser
President & CEO
Redwood City, CA
Trellis Bioscience Inc is a clinical-stage biotechnology company developing native human monoclonal antibodies.
sryser@trellisbio.com+1 917 880 1638
Checked
LTZ Therapeutics
Robert Li
Founder, CEO
Redwood City, CA
LTZ Therapeutics is a clinical-stage immunotherapy company developing bispecific antibody myeloid cell engagers.
robert.li@ltztherapeutics.com+1 314 956 7892
Checked
Orionis Biosciences
Nikolai Kley
Founder, President and CEO
Waltham, MA
Orionis Biosciences is a clinical-stage biotechnology company designing engineered protein medicines. Cytovance Biologics runs process development and cGMP manufacturing for antibodies, fusion proteins and enzymes.
7 more accounts are on the list for Cytovance Biologics, each with the person who signs off. They come with a short walkthrough call, and you keep the full list.
Where these accounts sit, counted from US Census business data.
Total addressable market
293
biological product makers in the US.
By buyer group
biological product makers293
SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total
By company size
Under 20 staff149
20 to 99 staff51
100 to 499 staff32
500 or more staff61
SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total
By state, on the list
California6
Massachusetts3
Florida1
New Jersey1
Pennsylvania1
SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026
Who signs off on the list
CEO11
President1
SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026
What the numbers say
01
About 5 in 10 biological product makers have under 20 staff. That is about 150 of them. 51 have 20 to 99 staff, 32 have 100 to 499 and 61 have 500 or more.
SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total
02
CEOs sign off most often. Of the 12 people who sign off, 11 are CEOs.
SourceThe list built for Cytovance Biologics, 12 accounts with the person who signs off at each, the first 5 with a work email and a phone checked Nov 4, 2026
03
Where the larger accounts sit. 32 of the biological product makers have 100 to 499 staff, and 61 have 500 or more.
SourceUS Census SUSB 2022, US employer firms, NAICS 325414 Biological Product Manufacturing, US total
03How it runs for you, from the list to the meeting.
In the engagement, intent data and fit pick the accounts. ECG's AI brain reads every reply, scores it and routes it. Your CRM and your team get the meeting, the record and the next step.
Intent and fit
Once it runs for you, intent data read with fit sets which accounts to reach first.
AI brain
ECG's own AI reads every reply, scores it and routes it to the right person.
The person who signs off
Name, title, work email and phone for each account, checked before anyone reaches out.
Workflow automation
The meeting lands in your calendar, the record lands in your CRM, and the rep gets the alert.
Intent data
Email replies
LinkedIn replies
Phone calls
Website inquiries
Your CRM
ECG AI brain
Reads, scores and routes
Meeting booked
Account scored
Rep alerted
Personal reply sent
CRM record updated
Next step scheduled
Every reply and every intent signal goes through one brain, then out to your calendar, your CRM and your team.
Build, Run, Own
Enquirer Consulting Group
Build.Run.Own.
01Build.
Built for Cytovance Biologics
The list, the messages, the CRM link and the workflows, set up for your market.
02Run.
Run live with your team for four months
We run it with your team and prove it on your own numbers.
03Own.
Then you own it
We hand it over, and the system stays yours.
04What to expect
What we have achieved on our own outbound, and what happens next.
88
interested replies in one week, on our own outbound
SourceInterested replies to our own outbound, one per person, Oct 12 to Oct 18, 2026, read October 18, 2026
31
sales calls booked that same week, on our own outbound
SourceECG booking table, sales calls booked Oct 12 to Oct 18, 2026, one per person, read November 4, 2026
19
industries our own outbound runs in
SourceECG fleet plan, read October 17, 2026
These are our own results. Your numbers depend on your market and your offer.
Recent work includes outreach for BOY Machines, sent in each field rep's own name.
What happens next
1Ben walks you through all 12 accounts on a short call.
2You keep the full list.
3If it fits, we map how the outbound unit runs for Cytovance Biologics.